London · Delayed Price · Currency is GBP · Price in GBX Shield Therapeutics Statistics
Total Valuation
AIM:STX has a market cap or net worth of GBP 49.86 million. The enterprise value is 62.34 million.
| Market Cap | 49.86M |
| Enterprise Value | 62.34M |
Important Dates
The next estimated earnings date is Wednesday, September 16, 2026.
| Earnings Date | Sep 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:STX has 1.07 billion shares outstanding. The number of shares has increased by 16.25% in one year.
| Current Share Class | 1.07B |
| Shares Outstanding | 1.07B |
| Shares Change (YoY) | +16.25% |
| Shares Change (QoQ) | +1.46% |
| Owned by Insiders (%) | 1.70% |
| Owned by Institutions (%) | 32.48% |
| Float | 413.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.13 |
| PB Ratio | -3.89 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 50.15 |
| P/OCF Ratio | 48.25 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 62.71 |
Financial Position
The company has a current ratio of 0.75
| Current Ratio | 0.75 |
| Quick Ratio | 0.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 18.88 |
| Interest Coverage | -0.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -4.37% |
| Return on Invested Capital (ROIC) | -25.22% |
| Return on Capital Employed (ROCE) | -51.40% |
| Weighted Average Cost of Capital (WACC) | 15.36% |
| Revenue Per Employee | 724,355 |
| Profits Per Employee | -128,166 |
| Employee Count | 61 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 3.54 |
Taxes
In the past 12 months, AIM:STX has paid 418,304 in taxes.
| Income Tax | 418,304 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.48% in the last 52 weeks. The beta is 1.77, so AIM:STX's price volatility has been higher than the market average.
| Beta (5Y) | 1.77 |
| 52-Week Price Change | -39.48% |
| 50-Day Moving Average | 5.25 |
| 200-Day Moving Average | 7.94 |
| Relative Strength Index (RSI) | 44.03 |
| Average Volume (20 Days) | 3,345,941 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:STX had revenue of GBP 44.19 million and -7.82 million in losses. Loss per share was -0.01.
| Revenue | 44.19M |
| Gross Profit | 23.04M |
| Operating Income | -3.05M |
| Pretax Income | -7.40M |
| Net Income | -7.82M |
| EBITDA | -3.34M |
| EBIT | -3.05M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 6.29 million in cash and 18.77 million in debt, with a net cash position of -12.48 million or -0.01 per share.
| Cash & Cash Equivalents | 6.29M |
| Total Debt | 18.77M |
| Net Cash | -12.48M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -12.83M |
| Book Value Per Share | -0.01 |
| Working Capital | -8.59M |
Cash Flow
In the last 12 months, operating cash flow was 1.03 million and capital expenditures -39,192, giving a free cash flow of 994,131.
| Operating Cash Flow | 1.03M |
| Capital Expenditures | -39,192 |
| Depreciation & Amortization | -280,201 |
| Net Borrowing | -2.30M |
| Free Cash Flow | 994,131 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 52.14%, with operating and profit margins of -6.91% and -17.69%.
| Gross Margin | 52.14% |
| Operating Margin | -6.91% |
| Pretax Margin | -16.75% |
| Profit Margin | -17.69% |
| EBITDA Margin | -7.55% |
| EBIT Margin | -6.91% |
| FCF Margin | 2.29% |
Dividends & Yields
AIM:STX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.25% |
| Shareholder Yield | -16.25% |
| Earnings Yield | -15.68% |
| FCF Yield | 1.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for AIM:STX is 16.67, which is 257.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 16.67 |
| Price Target Difference | 257.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 32.81% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AIM:STX has an Altman Z-Score of -5.73 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.73 |
| Piotroski F-Score | 5 |